Invasive disease-free survival and gene expression signatures in CALGB (Alliance) 40601, a randomized phase III neoadjuvant trial of dual HER2-targeting with lapatinib added to chemotherapy plus trastuzumab Meeting Abstract
| Authors: | Krop, I. E.; Hillman, D.; Polley, M. Y.; Tanioka, M.; Parker, J.; Huebner, L.; Henry, N. L.; Tolaney, S. M.; Dang, C.; Harris, L.; Berry, D. A.; Perou, C. M.; Partridge, A.; Winer, E. P.; Carey, L. A. |
| Abstract Title: | Invasive disease-free survival and gene expression signatures in CALGB (Alliance) 40601, a randomized phase III neoadjuvant trial of dual HER2-targeting with lapatinib added to chemotherapy plus trastuzumab |
| Meeting Title: | 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Dec 5-9 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000425489400016 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS17-GS3-02 |
| Notes: | Meeting Abstract: GS3-02 -- Source: Wos |
